Get in Touch

We are passionate about partnership.
Discover how we solve access, reimbursement and other complex issues in our case studies

Services

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Access Strategy, Price Optimisation

P4A partnered with Company A to assist in developing the launch strategy for Product A in South Korea

  • Access Strategy

P4A developed a bespoke Launch Guidebook to ensure the successful launch of a new asset

  • Digital Solutions

To determine strategies for maximising price, reimbursement and market access (PRMA) potential, considering the competitive landscape and different data scenarios

  • Access Strategy, Price Optimisation

Understand payer requirements and the role of key evidence types in estimating gene therapy durability in payer assessments

  • Value Communication

Supporting launch event for GT (large pharma)

  • Value Communication

To understand the key regulatory and competitive landscape changes that could impact a South Korean drug launch.

  • Access Strategy

Develop a patient engagement plan to support the launch of Product X and optimize PRMA outcomes via the incorporation of the patient voice

  • Value Communication

Support the UK patient organization in their engagement with NICE for the assessment of a new oncology product

  • Access Strategy, Value Communication

We supported a top 10 pharma in creating meaningful and actionable Competitor Intelligence insights in the gene therapy space​

  • Digital Solutions

We supported a mid-size company to assess the opportunity for a gene therapy platform they were planning on in-licensing​

  • Access Strategy, Price Optimisation

We helped an early stage biotech with their search strategy for a co-development partner for their CAR-T platform​

  • Access Strategy

We conducted a risk and opportunity assessment of undergoing joint HTA initiative for a GT ​

  • Access Strategy

We developed a GT monthly tracker for large pharma with multiple GT assets in pipeline ​

  • Value Communication, Digital Solutions

We developed creative solutions to showcase value differentiation for a third-to-market GT ​

  • Value Communication
Load More
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

  • Aramislaan 88,
  • 6213BV Maastricht, Netherlands
  • +31 6 55 88 71 96
  • contact@partners4access.com